Patent US4959301A successfully refreshed from Google Patents.
US4959301A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for rapidly enumerating viable entities
Assignee: Massachusetts Institute of Technology
•
Filing: 1988-04-22
•
Granted: 1990-09-25
•
Expires: 2008-04-22
Abstract
Abstract A process for rapidly enumerating viable biological entities is disclosed, wherein viability is determined by the critierion of growth of biological entities contained in microdroplets. Alternatively, in some cases, viability is determined by use of vital staining of biological entities contained in microdroplets. The process involves formation of microdroplets, which are very small volume liquid or gel particles, such that some of the microdroplets contain biololgical entities, followed by measurements of biological entities and of microdroplet volumes, such that use of statistical analysis can be used self-consistently to determine the number of viable entities per volume of a sample.
Inventors
- 👤 James C. Weaver
- 👤 Jonathan G. Bliss
- 👤 Gregory B. Williams
- 👤 Kevin T. Powell
- 👤 Gail I. Harrison
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 03:54
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/02; C12Q1/24; C12Q1/18; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
109 words
A method of determining the number of viable biological entities capable of growth per volume of a sample, comprising: (a) forming microdroplets from a volume of the sample wherein some but not all of the microdroplets contain viable biological entities; (b) measuring the volumes of at least a portion of the microdroplets formed in step (a) to obtain the volumes of the microdroplets; (c) measuring the amount of biological material which constitutes part of the viable biological entities in the microdroplets; and (d) determining the statistical distribution of the biological material in the microdroplet volumes as indicative of the number of viable biological entities per volume of the sample.
Claim 2
Independent Claim
109 words
A method of determining the number of viable biological entities capable of growth per volume of a sample, comprising: (a) forming microdroplets from a volume of the sample wherein some but not all of the microdroplets contain viable biological entities; (b) measuring the volumes of at least a portion of the microdroplets formed in step (a) to obtain the volumes of the microdroplets; (c) measuring the amount of biological material which constitutes part of the viable biological entities in the microdroplets; and (d) determining the statistical distribution of the biological material in the microdroplet volumes as indicative of the number of viable biological entities per volume of the sample.
Claim 3
Dependent Claim
35 words
A method of claim 1 wherein the amount of biological material is measured in step (c) by exposing the microdroplets to at least one vital stain thereby staining the viable biological entities in the microdroplets.
Claim 4
Dependent Claim
33 words
A method of claim 2 wherein the vital stain is selected from the group consisting of stain indicative of biological composition, stain indicative of enzyme activity, and stain indicative of cell membrane integrity.
Claim 5
Dependent Claim
37 words
A method of claim 1, including the additional step of incubating, prior to step (b), microdroplets under conditions whereby viable biological entities in the microdroplets produce a change in the amount of biological material within the microdroplets.
Claim 6
Dependent Claim
54 words
A method of claim 4 wherein the measurement of the amount of biological material accumulated within the microdroplets after incubation is enhanced by staining the biological material with a stain selected from the group consisting of fluorescent stains, light absorbance stains and light scattering stains to enhance the optical properties of the biological material.
Claim 7
Dependent Claim
43 words
A method of claim 5 wherein the stain is selected from the group consisting of nucleic acids stains, protein stains, lipid stains, cell membrane stains, cell wall stains, stains responsive to enzyme activity, stains responsive to transmembrane potentials and cell surface receptor stains.
Claim 8
Dependent Claim
26 words
A method of claim 1 wherein the biological entities are selected from the group consisting of multicellular organisms, groups of cells, individual cells, protoplasts, and viruses.
Claim 9
Dependent Claim
35 words
A method of claim 7 wherein the groups of cells or individual cells are selected from the group consisting of animal cells, plant cells, insect cells, bacterial cells, yeast cells, fungi cells and mold cells.
Claim 10
Dependent Claim
28 words
A method of claim 8 wherein the biological entities are selected from a group consisting of human cells, human cancer cells, pathogenic bacteria, pathogenic yeast, mycoplasms and parasites.
Claim 11
Dependent Claim
34 words
A method of claim 1 wherein the biological material is measured by a physical means selected from the group consisting of optical, weighing, sedimentation, field flow sedimentation fractionation, acoustic, magnetic, electrical and thermal means.
Claim 12
Dependent Claim
34 words
A method of claim 10 wherein biological material and microdroplet volumes are measured optically and wherein the optical means is selected from the group consisting of light scattering, light absorbance, fluorescence, phosphorescence and chemiluminescence.
Claim 13
Dependent Claim
45 words
A method of claim 11 wherein the amount of biological material is measured optically and wherein the optical measurement is performed by a means selected from the group consisting of flow cytometry, flow-though-microfluorimetry, optical particle analyzers, fluorescence microscopy, light microscropy, image analysis and video recording.
References Cited (Backward Citations)
US4399219A
Cited
US4401755A
Cited
US4643968A
Cited
US4647536A
Cited
EP0109861A2
Cited
EP0114756A2
Cited
US4649109A
Cited
US4801529A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-09-24 | 1994-03-26 | 1994-09-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-09-24 | 1998-03-26 | 1998-09-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-09-24 | 2002-03-26 | 2002-09-25 | $7700.00 | Window Closed / Lapsed |